Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
Authors
Keywords
Consensus, Tregs, Monitoring, Flow cytometry, Phenotyping
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 10, Pages 1271-1286
Publisher
Springer Nature
Online
2015-06-28
DOI
10.1007/s00262-015-1729-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
- (2015) Charlotte R. Grant et al. AUTOIMMUNITY REVIEWS
- Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
- (2014) Johannes Landskron et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation
- (2014) Kate S. Smigiel et al. IMMUNOLOGICAL REVIEWS
- The Percentage of FoxP3+Helios+ Treg Cells Correlates Positively With Disease Activity in Systemic Lupus Erythematosus
- (2013) Amit Golding et al. ARTHRITIS AND RHEUMATISM
- Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
- (2013) H-B Jie et al. BRITISH JOURNAL OF CANCER
- Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
- (2013) Theresa L. Whiteside CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD147 in regulatory T cells
- (2013) Johannes Landskron et al. CELLULAR IMMUNOLOGY
- Decreased CD127 Expression on CD4+ T-Cells and Elevated Frequencies of CD4+CD25+CD127− T-Cells in Children with Long-Lasting Type 1 Diabetes
- (2013) Marcin Moniuszko et al. Clinical & Developmental Immunology
- A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI)
- (2013) Lisa K. McNeil et al. CYTOMETRY PART A
- Helios+ and Helios- Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans
- (2013) M. E. Himmel et al. JOURNAL OF IMMUNOLOGY
- Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
- (2013) M Scurr et al. Mucosal Immunology
- Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
- (2013) Greg M. Delgoffe et al. NATURE
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Foxp3+Helios+regulatory T cells are expanded in active systemic lupus erythematosus
- (2012) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells
- (2012) T. Duhen et al. BLOOD
- The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools
- (2012) Satwinder Kaur Singh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Harmonization of the intracellular cytokine staining assay
- (2012) Marij J. P. Welters et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- OMIP-006: Phenotypic subset analysis of human T regulatory cells via polychromatic flow cytometry
- (2012) David M. Murdoch et al. CYTOMETRY PART A
- Phenotypic and functional characteristics of CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
- (2012) Patrick J. Schuler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
- (2012) C.M. Britten et al. IMMUNITY
- A Converse 4-1BB and CD40 Ligand Expression Pattern Delineates Activated Regulatory T Cells (Treg) and Conventional T Cells Enabling Direct Isolation of Alloantigen-Reactive Natural Foxp3+ Treg
- (2012) A. Schoenbrunn et al. JOURNAL OF IMMUNOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- What are regulatory T cells (Treg) regulating in cancer and why?
- (2012) Theresa L. Whiteside SEMINARS IN CANCER BIOLOGY
- CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells
- (2011) T. Solstad et al. BLOOD
- T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus
- (2011) Matthew J. Loza et al. CELLULAR IMMUNOLOGY
- Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets
- (2011) Patrick J. Schuler et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Expression of Helios in Peripherally Induced Foxp3+ Regulatory T Cells
- (2011) R. A. Gottschalk et al. JOURNAL OF IMMUNOLOGY
- Identification of Human Regulatory T Cells in the Setting of T-Cell Activation and Anti–CTLA-4 Immunotherapy on the Basis of Expression of Latency-Associated Peptide
- (2011) Jingjing Sun et al. Cancer Discovery
- FOXP3 and GARP (LRRC32): the master and its minion
- (2010) Michael Probst-Kepper et al. Biology Direct
- An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer
- (2010) Peggy J. de Vos van Steenwijk et al. CANCER RESEARCH
- Association of two clones allows for optimal detection of human FOXP3
- (2010) Pietro Presicce et al. CYTOMETRY PART A
- The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors
- (2010) Moniek Heusinkveld et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells
- (2010) A. M. Thornton et al. JOURNAL OF IMMUNOLOGY
- Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
- (2010) M. J. P. Welters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
- (2009) D. Q. Tran et al. BLOOD
- Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
- (2009) Alessandra Battaglia et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
- (2009) Ulf Petrausch et al. CURRENT MOLECULAR MEDICINE
- Neuropilin‐1 is not a marker of human Foxp3+Treg
- (2009) Pierre Milpied et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Fate of Human Treg Cells
- (2009) Manuela Battaglia et al. IMMUNITY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+Regulatory T Cells
- (2009) Magis Mandapathil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression
- (2009) Magis Mandapathil et al. JOURNAL OF IMMUNOLOGICAL METHODS
- GARP (LRRC32) is essential for the surface expression of latent TGF- on platelets and activated FOXP3+ regulatory T cells
- (2009) D. Q. Tran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
- (2008) B. Kavanagh et al. BLOOD
- CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells
- (2008) M. Kleinewietfeld et al. BLOOD
- Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine
- (2008) M. J.P. Welters et al. CLINICAL CANCER RESEARCH
- Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients
- (2008) Jean Grant et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- T-regulatory cells in tumour-specific vaccination strategies
- (2008) Marij JP Welters et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor-specific regulatory T cells in cancer patients
- (2008) Sytse J. Piersma et al. HUMAN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now